Skip to content
  • Wednesday, 15 April 2026
  • 10:17 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Telomir Pharmaceuticals Submits Investigational New Drug Application for Telomir-1 to FDA for Advanced Triple-Negative Breast Cancer
Pharmaceutical R&D

Telomir Pharmaceuticals Submits Investigational New Drug Application for Telomir-1 to FDA for Advanced Triple-Negative Breast Cancer

Teuku Ryan Apr 2, 2026 0

Telomir Pharmaceuticals has taken a significant stride in its mission to combat advanced and metastatic triple-negative breast cancer (TNBC) by…

Read More
Accelerated Pathways: A Strategic Approach to Fast-Track Qualifications in Today’s Dynamic Career LandscapeScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Python Decorators Revolutionize Data Pipeline Performance and Reliability for Data Science and Machine LearningResearchers at Chiba University Develop Viciazite Carbon Materials to Enable Low-Temperature Carbon Dioxide Capture and Reduce Industrial Emissions
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityLLMOps in 2026: The 10 Tools Every Team Must HaveWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic InterruptionThe Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line DevelopmentImmuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure ThroughputMental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic Interruption
Dwi Wanna Apr 15, 2026
Biotech & Genetic Research
The Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line Development
Jia Lissa Apr 15, 2026
Laboratory Automation & Robotics
Immuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure Throughput
Lana Keisha Apr 15, 2026
Neuroscience & Brain Research
Mental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study
Rifan Muazin Apr 15, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ